Sun C - Search Results

1

Differential expression profiles of circRNAs in human prostate cancer based on chip and bioinformatic analysis.

Ge S, Sun C, Hu Q, Guo Y, Xia G, Mi Y, Zhu L. Ge S, et al. Among authors: sun c. Int J Clin Exp Pathol. 2020 May 1;13(5):1045-1052. eCollection 2020. Int J Clin Exp Pathol. 2020. PMID: 32509077 Free PMC article.

2

[Application of iTRAQ in proteomic study of prostate cancer].

Sun CY, Xia GW, Xu K, Ding Q. Sun CY, et al. Zhonghua Nan Ke Xue. 2010 Aug;16(8):741-4. Zhonghua Nan Ke Xue. 2010. PMID: 21090353 Review. Chinese.

3

Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy.

Sun C, Song C, Ma Z, Xu K, Zhang Y, Jin H, Tong S, Ding W, Xia G, Ding Q. Sun C, et al. Proteome Sci. 2011 Apr 19;9:22. doi: 10.1186/1477-5956-9-22. Proteome Sci. 2011. PMID: 21504578 Free PMC article.

4

Periostin: a promising target of therapeutical intervention for prostate cancer.

Sun C, Zhao X, Xu K, Gong J, Liu W, Ding W, Gou Y, Xia G, Ding Q. Sun C, et al. J Transl Med. 2011 Jun 30;9:99. doi: 10.1186/1479-5876-9-99. J Transl Med. 2011. PMID: 21714934 Free PMC article.

5

The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.

Chen Z, Ding W, Xu K, Tan J, Sun C, Gou Y, Tong S, Xia G, Fang Z, Ding Q. Chen Z, et al. Among authors: sun c. PLoS One. 2012;7(10):e47199. doi: 10.1371/journal.pone.0047199. Epub 2012 Oct 17. PLoS One. 2012. PMID: 23082147 Free PMC article.

6

A systematic review and meta-analysis of current evidence comparing laparoendoscopic single-site adrenalectomy and conventional laparoscopic adrenalectomy.

Hu Q, Gou Y, Sun C, Xu K, Xia G, Ding Q. Hu Q, et al. Among authors: sun c. J Endourol. 2013 Jun;27(6):676-83. doi: 10.1089/end.2012.0687. Epub 2013 Apr 3. J Endourol. 2013. PMID: 23391020 Review.

7

Synthesis and characterization of superparamagnetic CoFe2O4/MWCNT hybrids for tumor-targeted therapy.

Sun C, Liu Y, Ding W, Gou Y, Xu K, Xia G, Ding Q. Sun C, et al. J Nanosci Nanotechnol. 2013 Jan;13(1):236-41. doi: 10.1166/jnn.2013.6711. J Nanosci Nanotechnol. 2013. PMID: 23646722

8

The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.

Hu Q, Gou Y, Sun C, Ding W, Xu K, Gu B, Xia G, Ding Q. Hu Q, et al. Among authors: sun c. Urol Oncol. 2014 Jan;32(1):50.e1-8. doi: 10.1016/j.urolonc.2013.07.016. Epub 2013 Nov 13. Urol Oncol. 2014. PMID: 24239465 Review.

9

Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.

Ding W, Gou Y, Sun C, Xia G, Wang H, Chen Z, Tan J, Xu K, Qiang D. Ding W, et al. Among authors: sun c. Urol Oncol. 2014 Jan;32(1):42.e13-9. doi: 10.1016/j.urolonc.2013.05.004. Urol Oncol. 2014. PMID: 24360660

10

Are EORTC risk tables suitable for Chinese patients with non-muscle-invasive bladder cancer?

Ding W, Chen Z, Gou Y, Sun C, Xu K, Tan J, Tong S, Xia G, Ding Q. Ding W, et al. Among authors: sun c. Cancer Epidemiol. 2014 Apr;38(2):157-61. doi: 10.1016/j.canep.2014.02.001. Epub 2014 Mar 11. Cancer Epidemiol. 2014. PMID: 24629527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,995 results

Search Page

Filters